| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,800 | 11,233 | 11,029 | 12,444 | | Cost of Revenue | 3,103 | 3,512 | 3,781 | 3,977 | | | Gross Profit |
-
| 7,721 | 7,248 | 8,467 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,894 | 6,557 | 5,849 | 5,982 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 30,195 | 2,445 | 3,521 | 1,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (1,281) | (2,122) | 885 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (32,392) | (1,281) | (2,122) | 885 | | Interest Expense | 449 | 547 | 645 | 842 | | Income Before Tax | (32,841) | (1,828) | (2,767) | 43 | | Income Tax Expense | (9,614) | (892) | (1,264) | (150) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,227) | (936) | (1,503) | 193 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (23,227) | (936) | (1,503) | 193 | | Preferred Stock And Other Adjustments | (222) | (222) | (62) |
-
| | | Net Income Applicable To Common Shares | ($23,449) | ($1,158) | ($1,565) | $193 |
|
0.01% Nasdaq 
0.22 (8.43%) 
Income Statement
